Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28140
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCox, Narelle S-
dc.contributor.authorHolland, Anne E-
dc.date2018-11-30-
dc.date.accessioned2021-11-24T05:40:16Z-
dc.date.available2021-11-24T05:40:16Z-
dc.date.issued2019-01-
dc.identifier.citationExpert review of respiratory medicine 2019; 13(1): 13-22en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28140-
dc.description.abstractIntroduction: Regular exercise and physical activity participation are recommended in guideline-based care for individuals with cystic fibrosis (CF) across the spectrum of age and disease severity. However, the best training methods to improve physical function and encourage ongoing exercise and activity participation are not clear, which is an ongoing challenge for clinicians. Areas covered: This perspective provides an overview of current evidence for exercise and physical activity relative to clinical outcomes and health-care utilization in people with CF, and highlights areas of future research need. Expert commentary: What kind, how much, how often, and how best to support people with CF to be physically active is uncertain. Whether new methods of training, the use of technology, or pharmaceutical developments could best deliver increased activity and physiological benefit without increased therapeutic burden is unclear. At present, if people with CF are going to be physically active, seemingly they should aim to perform this activity in the way most likely to confer some health benefit i.e. concerted exercise bouts of at least 10 min in addition to any incidental (habitual) activity performed during the course of daily life.en
dc.language.isoeng
dc.subjectCystic fibrosisen
dc.subjectclinical outcomesen
dc.subjectexerciseen
dc.subjecthealth-care utilizationen
dc.subjectphysical activityen
dc.titleCurrent perspectives of physical activity in cystic fibrosis.en
dc.typeJournal Articleen
dc.identifier.journaltitleExpert review of respiratory medicineen
dc.identifier.affiliationInstitute for Breathing and Sleepen
dc.identifier.affiliationYouth Activity Unlimited, Strategic Research Centre of the UK Cystic Fibrosis Trusten
dc.identifier.affiliationDepartment of Physiotherapy, Alfred Hospital, Melbourne, Australiaen
dc.identifier.affiliationDiscipline of Physiotherapy, La Trobe University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationYouth Activity Unlimited, Strategic Research Centre of the UK Cystic Fibrosis Trusten
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/30484339/en
dc.identifier.doi10.1080/17476348.2019.1552833en
dc.type.contentTexten
dc.identifier.orcid0000-0003-2061-845Xen
dc.identifier.orcid0000-0002-6977-1028en
dc.identifier.pubmedid30484339
local.name.researcherCox, Narelle S
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptPhysiotherapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Nov 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.